Transient cerebral ischemia promotes brain mitochondrial dysfunction and exacerbates cognitive impairments in young 5xFAD mice

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Lu, Lin ^a,b   Guo, Lan ^a   Gauba, Esha ^a   Tian, Jing ^a   Wang, Lu ^a,b   Tandon, Neha ^a   Shankar, Malini ^a   Beck, Simon J ^a   Du, Yifeng ^b   Du, Heng ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; MITOCHONDRIAL PROTEIN; MITOFUSIN 2; OPTIC ATROPHY 1 PROTEIN; SUPEROXIDE; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN;

5XFAD MOUSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; BRAIN MITOCHONDRION; CAROTID ARTERY OBSTRUCTION; COGNITIVE DEFECT; CONTROLLED STUDY; JUVENILE ANIMAL; MITOCHONDRIAL RESPIRATION; MOUSE; NERVE CELL NECROSIS; NONHUMAN; OXIDATIVE STRESS; SPATIAL LEARNING; SPATIAL MEMORY; ALZHEIMER DISEASE; ANIMAL; COGNITION DISORDERS; COMPLICATION; METABOLISM; MITOCHONDRION; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSIENT ISCHEMIC ATTACK;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; COGNITION DISORDERS; ISCHEMIC ATTACK, TRANSIENT; MICE; MITOCHONDRIA; OXIDATIVE STRESS;

EID: 84955490680     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0144068     Document Type: Article

References (71)

1. Querfurth HW, LaFerla FM. Alzheimer's disease. The New England journal of medicine. 2010; 362(4):329-44. doi: 10.1056/NEJMra0909142 PMID: 20107219.
2. Swerdlow RH, Burns JM, Khan SM. The Alzheimer's disease mitochondrial cascade hypothesis. Journal of Alzheimer's disease: JAD. 2010; 20 Suppl 2:S265-79. doi: 10.3233/JAD-2010-100339 PMID: 20442494; PubMed Central PMCID: PMC2883665.
3. Johnson KA, Jones K, Holman BL, Becker JA, Spiers PA, Satlin A, et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology. 1998; 50(6):1563-71. PMID: 9633695.
4. Skoog I, Gustafson D. Update on hypertension and Alzheimer's disease. Neurological research. 2006; 28(6):605-11. doi: 10.1179/016164106X130506 PMID: 16945211.
5. Silvestrini M, Viticchi G, Falsetti L, Balucani C, Vernieri F, Cerqua R, et al. The role of carotid atherosclerosis in Alzheimer's disease progression. Journal of Alzheimer's disease: JAD. 2011; 25(4):719-26. doi: 10.3233/JAD-2011-101968 PMID: 21508532.
6. Guerreiro RJ, Gustafson DR, Hardy J. The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. Neurobiology of aging. 2012; 33(3):437-56. doi: 10.1016/j.neurobiolaging.2010.03.025 PMID: 20594621; PubMed Central PMCID: PMC2980860.
7. Huang CC, Chung CM, Leu HB, Lin LY, Chiu CC, Hsu CY, et al. Diabetes mellitus and the risk of Alzheimer's disease: a nationwide population-based study. PloS one. 2014; 9(1):e87095. doi: 10.1371/journal.pone.0087095 PMID: 24489845; PubMed Central PMCID: PMC3906115.
8. Cook M, Baker N, Lanes S, Bullock R, Wentworth C, Arrighi HM. Incidence of stroke and seizure in Alzheimer's disease dementia. Age and ageing. 2015. doi: 10.1093/ageing/afv061 PMID: 26008894.
9. Zhu X, Smith MA, Honda K, Aliev G, Moreira PI, Nunomura A, et al. Vascular oxidative stress in Alzheimer disease. Journal of the neurological sciences. 2007; 257(1-2):240-6. doi: 10.1016/j.jns.2007.01.039 PMID: 17337008; PubMed Central PMCID: PMC1952687.
10. White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross GW, et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Annals of the New York Academy of Sciences. 2002; 977:9-23. PMID: 12480729.
11. Kemppainen S, Hamalainen E, Miettinen PO, Koistinaho J, Tanila H. Behavioral and neuropathological consequences of transient global ischemia in APP/PS1 Alzheimer model mice. Behavioural brain research. 2014; 275:15-26. doi: 10.1016/j.bbr.2014.08.050 PMID: 25192639.
12. Zhang F, Eckman C, Younkin S, Hsiao KK, Iadecola C. Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein. The Journal of neuroscience: the official journal of the Society for Neuroscience. 1997; 17(20):7655-61. PMID: 9315887.
13. Pimentel-Coelho PM, Michaud JP, Rivest S. Effects of mild chronic cerebral hypoperfusion and early amyloid pathology on spatial learning and the cellular innate immune response in mice. Neurobiology of aging. 2013; 34(3):679-93. doi: 10.1016/j.neurobiolaging.2012.06.025 PMID: 22819135.
14. Troncoso JC, Zonderman AB, Resnick SM, Crain B, Pletnikova O, O'Brien RJ. Effect of infarcts on dementia in the Baltimore longitudinal study of aging. Annals of neurology. 2008; 64(2):168-76. doi: 10.1002/ana.21413 PMID: 18496870; PubMed Central PMCID: PMC2694129.
15. Sun YY, Li Y, Wali B, Li Y, Lee J, Heinmiller A, et al. Prophylactic Edaravone Prevents Transient Hypoxic-Ischemic Brain Injury: Implications for Perioperative Neuroprotection. Stroke; a journal of cerebral circulation. 2015. doi: 10.1161/STROKEAHA.115.009162 PMID: 26060244.
16. Yates D. Cell biology of the neuron: fuelling transport. Nature reviews Neuroscience. 2013; 14(3):156. doi: 10.1038/nrn3463 PMID: 23422907.
17. Doll DN, Hu H, Sun J, Lewis SE, Simpkins JW, Ren X. Mitochondrial crisis in cerebrovascular endothelial cells opens the blood-brain barrier. Stroke; a journal of cerebral circulation. 2015; 46(6):1681-9. doi: 10.1161/STROKEAHA.115.009099 PMID: 25922503; PubMed Central PMCID: PMC4418219.
18. Chouchani ET, Pell VR, Gaude E, Aksentijevic D, Sundier SY, Robb EL, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014; 515(7527):431-5. doi: 10.1038/nature13909 PMID: 25383517; PubMed Central PMCID: PMC4255242.
19. Venna VR, Verma R, O'Keefe LM, Xu Y, Crapser J, Friedler B, et al. Inhibition of mitochondrial p53 abolishes the detrimental effects of social isolation on ischemic brain injury. Stroke; a journal of cerebral circulation. 2014; 45(10):3101-4. doi: 10.1161/STROKEAHA.114.006553 PMID: 25205311; PubMed Central PMCID: PMC4192598.
20. Vaseva AV, Marchenko ND, Ji K, Tsirka SE, Holzmann S, Moll UM. p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell. 2012; 149(7):1536-48. doi: 10.1016/j.cell.2012.05.014 PMID: 22726440; PubMed Central PMCID: PMC3383624.
21. Schinzel AC, Takeuchi O, Huang Z, Fisher JK, Zhou Z, Rubens J, et al. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102(34):12005-10. doi: 10.1073/pnas.0505294102 PMID: 16103352; PubMed Central PMCID: PMC1189333.
22. Du H, Guo L, Wu X, Sosunov AA, McKhann GM, Chen JX, et al. Cyclophilin D deficiency rescues Abeta-impaired PKA/CREB signaling and alleviates synaptic degeneration. Biochimica et biophysica acta. 2014; 1842(12 Part A):2517-27. doi: 10.1016/j.bbadis.2013.03.004 PMID: 23507145; PubMed Central PMCID: PMC3868643.
23. Guo L, Du H, Yan S, Wu X, McKhann GM, Chen JX, et al. Cyclophilin D deficiency rescues axonal mitochondrial transport in Alzheimer's neurons. PloS one. 2013; 8(1):e54914. doi: 10.1371/journal.pone.0054914 PMID: 23382999; PubMed Central PMCID: PMC3561411.
24. Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, et al. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nature medicine. 2008; 14(10):1097-105. doi: 10.1038/nm.1868 PMID: 18806802; PubMed Central PMCID: PMC2789841.
25. Du H, Guo L, Yan S, Sosunov AA, McKhann GM, Yan SS. Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proceedings of the National Academy of Sciences of the United States of America. 2010; 107(43):18670-5. doi: 10.1073/pnas.1006586107 PMID: 20937894; PubMed Central PMCID: PMC2972922.
26. Reddy PH, Beal MF. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends in molecular medicine. 2008; 14(2):45-53. doi: 10.1016/j.molmed.2007.12.002 PMID: 18218341; PubMed Central PMCID: PMC3107703.
27. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006; 443(7113):787-95. doi: 10.1038/nature05292 PMID: 17051205.
28. Eimer WA, Vassar R. Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Abeta42 accumulation and Caspase-3 activation. Molecular neurodegeneration. 2013; 8:2. doi: 10.1186/1750-1326-8-2 PMID: 23316765; PubMed Central PMCID: PMC3552866.
29. Rojas S, Herance JR, Gispert JD, Abad S, Torrent E, Jimenez X, et al. In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography. Neurobiology of aging. 2013; 34(7):1790-8. doi: 10.1016/j.neurobiolaging.2012.12.027 PMID: 23402900.
30. Jawhar S, Wirths O, Schilling S, Graubner S, Demuth HU, Bayer TA. Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice. The Journal of biological chemistry. 2011; 286(6):4454-60. doi: 10.1074/jbc.M110.185819 PMID: 21148560; PubMed Central PMCID: PMC3039372.
31. Girard SD, Baranger K, Gauthier C, Jacquet M, Bernard A, Escoffier G, et al. Evidence for early cognitive impairment related to frontal cortex in the 5XFAD mouse model of Alzheimer's disease. Journal of Alzheimer's disease: JAD. 2013; 33(3):781-96. doi: 10.3233/JAD-2012-120982 PMID: 23042214.
32. Costantini LC, Barr LJ, Vogel JL, Henderson ST. Hypometabolism as a therapeutic target in Alzheimer's disease. BMC Neurosci. 2008; 9 Suppl 2:S16. Epub 2009/01/06. doi: 10.1186/1471-2202-9-S2-S16 PMID: 19090989; PubMed Central PMCID: PMC2604900.
33. Yates D. Cell biology of the neuron: fuelling transport. Nat Rev Neurosci. 2013; 14(3):156. Epub 2013/02/21. doi: 10.1038/nrn3463 PMID: 23422907.
34. Du C, Hu R, Csernansky CA, Hsu CY, Choi DW. Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. 1996; 16(2):195-201. doi: 10.1097/00004647-199603000-00003 PMID: 8594050.
35. Winters A, Taylor JC, Ren M, Ma R, Liu R, Yang SH. Transient focal cerebral ischemia induces long-term cerebral vasculature dysfunction in a rodent experimental stroke model. Translational stroke research. 2012; 3(2):279-85. doi: 10.1007/s12975-012-0148-y PMID: 22899969; PubMed Central PMCID: PMC3418819.
36. Zhang Q, Gao T, Luo Y, Chen X, Gao G, Gao X, et al. Transient focal cerebral ischemia/reperfusion induces early and chronic axonal changes in rats: its importance for the risk of Alzheimer's disease. PloS one. 2012; 7(3):e33722. doi: 10.1371/journal.pone.0033722 PMID: 22457786; PubMed Central PMCID: PMC3311543.
37. Keating DJ. Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases. Journal of neurochemistry. 2008; 104(2):298-305. doi: 10.1111/j.1471-4159.2007.04997.x PMID: 17961149.
38. Dalleau S, Baradat M, Gueraud F, Huc L. Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance. Cell death and differentiation. 2013; 20(12):1615-30. doi: 10.1038/cdd.2013.138 PMID: 24096871; PubMed Central PMCID: PMC3824598.
39. Higgins GC, Beart PM, Shin YS, Chen MJ, Cheung NS, Nagley P. Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury. Journal of Alzheimer's disease: JAD. 2010; 20 Suppl 2:S453-73. doi: 10.3233/JAD-2010-100321 PMID: 20463398.
40. Mukhopadhyay P, Rajesh M, Yoshihiro K, Hasko G, Pacher P. Simple quantitative detection of mitochondrial superoxide production in live cells. Biochemical and biophysical research communications. 2007; 358(1):203-8. doi: 10.1016/j.bbrc.2007.04.106 PMID: 17475217; PubMed Central PMCID: PMC2228267.
41. Zhu X, Perry G, Smith MA, Wang X. Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. Journal of Alzheimer's disease: JAD. 2013; 33 Suppl 1:S253-62. doi: 10.3233/JAD-2012-129005 PMID: 22531428; PubMed Central PMCID: PMC4097015.
42. Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, et al. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2009; 29(28):9090-103. doi: 10.1523/JNEUROSCI.1357-09.2009 PMID: 19605646; PubMed Central PMCID: PMC2735241.
43. Bonda DJ, Wang X, Perry G, Smith MA, Zhu X. Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies. Drugs & aging. 2010; 27(3):181-92. doi: 10.2165/11532140-000000000-00000 PMID: 20210366; PubMed Central PMCID: PMC2923854.
44. Taguchi N, Ishihara N, Jofuku A, Oka T, Mihara K. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. The Journal of biological chemistry. 2007; 282(15):11521-9. doi: 10.1074/jbc.M607279200 PMID: 17301055.
45. Manczak M, Reddy PH. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage. Human molecular genetics. 2012; 21(11):2538-47. doi: 10.1093/hmg/dds072 PMID: 22367970; PubMed Central PMCID: PMC3349426.
46. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science. 2004; 304(5669):448-52. doi: 10.1126/science.1091230 PMID: 15087549.
47. Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, McDonald B, et al. Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia. 1995; 6(1):21-31. PMID: 7728216.
48. Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. Journal of neuropathology and experimental neurology. 2012; 71(5):362-81. doi: 10.1097/NEN.0b013e31825018f7 PMID: 22487856; PubMed Central PMCID: PMC3560290.
49. Jordan J, Cena V, Prehn JH. Mitochondrial control of neuron death and its role in neurodegenerative disorders. Journal of physiology and biochemistry. 2003; 59(2):129-41. PMID: 14649878.
50. Porporato PE, Payen VL, Perez-Escuredo J, De Saedeleer CJ, Danhier P, Copetti T, et al. A mitochondrial switch promotes tumor metastasis. Cell reports. 2014; 8(3):754-66. doi: 10.1016/j.celrep.2014.06.043 PMID: 25066121.
51. Wang X, Wang W, Li L, Perry G, Lee HG, Zhu X. Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. Biochimica et biophysica acta. 2014; 1842(8):1240-7. doi: 10.1016/j.bbadis.2013.10.015 PMID: 24189435; PubMed Central PMCID: PMC4007397.
52. Feely SM, Laura M, Siskind CE, Sottile S, Davis M, Gibbons VS, et al. MFN2 mutations cause severe phenotypes in most patients with CMT2A. Neurology. 2011; 76(20):1690-6. doi: 10.1212/WNL.0b013e31821a441e PMID: 21508331; PubMed Central PMCID: PMC3100135.
53. Ryu SW, Han EC, Yoon J, Choi C. The mitochondrial fusion-related proteins Mfn2 and OPA1 are transcriptionally induced during differentiation of bone marrow progenitors to immature dendritic cells. Molecules and cells. 2015; 38(1):89-94. doi: 10.14348/molcells.2015.2285 PMID: 25387754; PubMed Central PMCID: PMC4314123.
54. Karbowski M, Youle RJ. Dynamics of mitochondrial morphology in healthy cells and during apoptosis. Cell death and differentiation. 2003; 10(8):870-80. doi: 10.1038/sj.cdd.4401260 PMID: 12867994.
55. Ni HM, Williams JA, Ding WX. Mitochondrial dynamics and mitochondrial quality control. Redox biology. 2015; 4:6-13. doi: 10.1016/j.redox.2014.11.006 PMID: 25479550; PubMed Central PMCID: PMC4309858.
56. Ugarte-Uribe B, Garcia-Saez AJ. Membranes in motion: mitochondrial dynamics and their role in apoptosis. Biological chemistry. 2014; 395(3):297-311. doi: 10.1515/hsz-2013-0234 PMID: 24184992.
57. Martorell-Riera A, Segarra-Mondejar M, Munoz JP, Ginet V, Olloquequi J, Perez-Clausell J, et al. Mfn2 downregulation in excitotoxicity causes mitochondrial dysfunction and delayed neuronal death. The EMBO journal. 2014; 33(20):2388-407. doi: 10.15252/embj.201488327 PMID: 25147362; PubMed Central PMCID: PMC4253527.
58. Gan X, Huang S, Wu L, Wang Y, Hu G, Li G, et al. Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell. Biochimica et biophysica acta. 2014; 1842(2):220-31. doi: 10.1016/j.bbadis.2013.11.009 PMID: 24252614; PubMed Central PMCID: PMC3991235.
59. Reddy PH. Increased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fission. Drug discovery today. 2014; 19(7):951-5. doi: 10.1016/j.drudis.2014.03.020 PMID: 24681059; PubMed Central PMCID: PMC4191657.
60. Song W, Chen J, Petrilli A, Liot G, Klinglmayr E, Zhou Y, et al. Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nature medicine. 2011; 17(3):377-82. doi: 10.1038/nm.2313 PMID: 21336284; PubMed Central PMCID: PMC3051025.
61. Imai Y, Lu B. Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder. Current opinion in neurobiology. 2011; 21(6):935-41. doi: 10.1016/j.conb.2011.10.016 PMID: 22048001; PubMed Central PMCID: PMC3254859.
62. Lim KL, Ng XH, Grace LG, Yao TP. Mitochondrial dynamics and Parkinson's disease: focus on parkin. Antioxidants & redox signaling. 2012; 16(9):935-49. doi: 10.1089/ars.2011.4105 PMID: 21668405; PubMed Central PMCID: PMC3292756.
63. Qi JP, Wu H, Yang Y, Wang DD, Chen YX, Gu YH, et al. Cerebral ischemia and Alzheimer's disease: the expression of amyloid-beta and apolipoprotein E in human hippocampus. Journal of Alzheimer's disease: JAD. 2007; 12(4):335-41. PMID: 18198420.
64. Zhen G, Dore S. Optimized protocol to reduce variable outcomes for the bilateral common carotid artery occlusion model in mice. Journal of neuroscience methods. 2007; 166(1):73-80. doi: 10.1016/j.jneumeth.2007.06.029 PMID: 17692388; PubMed Central PMCID: PMC2039915.
65. Yoshioka H, Niizuma K, Katsu M, Sakata H, Okami N, Chan PH. Consistent injury to medium spiny neurons and white matter in the mouse striatum after prolonged transient global cerebral ischemia. Journal of neurotrauma. 2011; 28(4):649-60. doi: 10.1089/neu.2010.1662 PMID: 21309724; PubMed Central PMCID: PMC3070149.
66. Du H, Guo L, Zhang W, Rydzewska M, Yan S. Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model. Neurobiology of aging. 2011; 32(3):398-406. doi: 10.1016/j.neurobiolaging.2009.03.003 PMID: 19362755; PubMed Central PMCID: PMC3304024.
67. Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America. 1996; 93(7):2696-701. PMID: 8610103; PubMed Central PMCID: PMC39693.
68. Gage GJ, Kipke DR, Shain W. Whole animal perfusion fixation for rodents. Journal of visualized experiments: JoVE. 2012;(65:). doi: 10.3791/3564 PMID: 22871843; PubMed Central PMCID: PMC3476408.
69. Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protocols. 2006; 1(2):848-58. PMID: 17406317
70. Wappler EA, Institoris A, Dutta S, Katakam PV, Busija DW. Mitochondrial dynamics associated with oxygen-glucose deprivation in rat primary neuronal cultures. PloS one. 2013; 8(5):e63206. doi: 10.1371/journal.pone.0063206 PMID: 23658809; PubMed Central PMCID: PMC3642144.
71. Du H, Guo L, Yan S, Sosunov AA, McKhann GM, ShiDu Yan S. Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proceedings of the National Academy of Sciences. 2010; 107(43):18670-5. doi: 10.1073/pnas.1006586107